The epidemiology of mycetoma

Current Fungal Infection Reports

Volumn 6, Issue 4, 2012, Pages 320-326

  Fahal, A H ^a   Van De Sande, W W J ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Actinomycetoma; Epidemiology; Eumycetoma; Geographical distribution; Incidence; Incubation period; Infection route; Mycetoma; Susceptibility

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; AROMATASE; CATECHOL METHYLTRANSFERASE; CHEMOKINE RECEPTOR CXCR2; COMPLEMENT COMPONENT C3B RECEPTOR; CYTOCHROME P450 17; CYTOCHROME P450 1B1; ESTRADIOL; FUNGAL DNA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 8; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; NITRITE; RANTES; THROMBOSPONDIN; THROMBOSPONDIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTINOMADURA; ACTINOMADURA PELLETIERII; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DEFORMITY; DISABILITY; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; FOOT DISEASE; FUNGUS; FUNGUS IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HUMAN; INCIDENCE; INCUBATION TIME; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEPTOSPHAERIA SENEGALIENSIS; MADURELLA MYCETOMATIS; MORBIDITY; MYCETOMA; NOCARDIA; NONHUMAN; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PREVALENCE; PYRENOCHAETA ROMEROI; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEASONAL VARIATION; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOMYCES; STREPTOMYCES SOMALIENSIS;

EID: 84886725806     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-012-0102-1     Document Type: Article

References (47)

1. • Fahal AH. Mycetoma. Review article. Khartoum Med J. 2011;4(1):514-23. This article was recently published and it is a comprehensive updated review on mycetoma.
2. • Fahal AH. Mycetoma. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. 3rd ed. Philadelphia: Saunders-Elsevier; 2010. p. 234-9. This book was recently published and the chapter is a comprehensive updated review of the epidemiology, pathology and management of mycetoma.
3. • Fahal AH. Management of mycetoma. Expert Rev Dermatol. 2010;1:87-93. This recent article is a comprehensive updated review of the management of mycetoma.
4. Fahal AH, Hassan MA. Mycetoma. Br J Surg. 1992;79(11):1138-41.
5. Fahal AH. Mycetoma thorn on the flesh. Trans R Soc Trop Med Hyg. 2004;98(1):3-11.
6. Magana M. Mycetoma. Int J Dermatol. 1984;23(4):221-36.
7. Fahal AH. Mycetoma: Clinico-pathological Monograph. Khartoum: University of Khartoum Press; 2006.
8. Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004;4(9):566-74. Review.
9. Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis. 2007;20(2):146-51.
10. •• Mahgoub ES, Murray IG. Mycetoma. London: Heinemann; 1973. p. 1-50. This is the first comprehensive book on mycetoma and its epidemiology.
11. Abbott PH. Mycetoma in the Sudan. Trans Roy Soc Trop Med Hyg. 1956;50:11-24.
12. Lopez Martinez RL, Mendez Tovar J, Lavalle P, Welsh O, Saul A, Macotela Ruiz E. Epidemiology of mycetoma in Mexico: study of 2105 cases. Gac Med Mex. 1992;128:477-81.
13. •• Mariat F. Sur La distribution geographique et la repartition des agents de mycetomes. Bull Soc Pathol Exot. 1963;56:35-45. This article is a key article that reports the distribution of mycetoma worldwide.
14. Mahgoub ES. Mycetoma. Semin Dermatol. 1985;4:230.
15. Maiti PK, Ray A, Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health. 2002;7(9):788-92.
16. • Padhi S, Uppin SG, Uppin MS, et al. Mycetoma in South India: retrospective analysis of 13 cases and description of two cases caused by unusual pathogens: Neoscytalidium dimidiatum and Aspergillus flavus. Int J Dermatol. 2010;49(11):1289-96. This recent article is a comprehensive updated review of the epidemiology of mycetoma in India, a common endemic area for mycetoma.
17. Cameron HM, Gatei D, Bremner AD. The deep mycoses in Kenya: a histopathological study. Mycetoma. East Afr Med J. 1973;50(8):382-95.
18. Develoux M, Ndiaye B, Dieng MT. Mycetomas in Africa. Sante. 1995;5(4):211-7.
19. Agarwal SC, Mathur DR. Mycetoma in Northern Nigeria. Trop Geogr Med. 1985;37(2):133-5.
20. Hay RJ, Mackenzie DW. Mycetoma (Madura foot) in the United Kingdom - a survey of forty four cases. Clin Exp Dermatol. 1983;8:553-62.
21. • Patel S, Sethi A. Imported tropical diseases. Dermatol Ther. 2009;22(6):538-49. This article highlights the tropical diseases commonly imported to Western communities.
22. Malone M, Gannass A, Bowling F. A chronic, destructive mycetoma infection in a diabetic foot in Saudi Arabia. Int J Low Extrem Wounds. 2011;10(1):12-5.
23. Khatri ML, Al-Halali HM, Fouad Khalid M, Saif SA, Vyas MC. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study. Int J Dermatol. 2002;1(9):586-93.
24. Tight RR, Bartlell MS. Actinomycetoma in the United States. Rev Infect Dis. 1981;3:1139-50.
25. • Aounallah A, Boussofara L, Ben Saïd Z, Ghariani N, Saidi W, Denguezli M, et al. Analysis of 18 Tunisian cases of mycetoma at the Sousse hospital (1974-2010). Bull Soc Pathol Exot. 2012. doi: 10.1007/s13149-012-0233- 1. This recent article is a comprehensive updated review of the epidemiology in Tunisia where mycetoma is not a common problem.
26. Zarei Mahmoudabadi A, Zarrin M. Mycetomas in Iran: a review article. Mycopathologia. 2008;165(3):135-41.
27. Mariat F, Destombes P, Segretain G. The mycetomas: clinical features, pathology, etiology and epidemiology. Contrib Microbiol Immunol. 1977;4:1-39.
28. Gumaa SA. The aetiology and epidemiology of mycetoma. Sud Med J. 1994;32(Suppl):14-22.
29. Ahmed AO, Adelmann D, Fahal AH, Verbrugh HA, Van Belkum A, De Hoog S. Environmental occurrence of Madurella mycetomatis, major agent of human eumycetoma in Sudan. J Clin Microbiol. 2002;40(3):1031-6.
30. Gumaa SA, Mohamed FH, Mahgoub ES, Adam EE, El-Hassan AM, Imbabi SE. Mycetoma in goats. Sabouraudia. 1978;16:217-23.
31. Van Amstel SR, Ross M, Van der Bergh SS. Maduromycosis (Madurella mycetomatis) infection in a horse. JS Afr Vet Assoc. 1984;55(2):81-3.
32. Batul MA, Al-Asha, F, Mohamed EA, Isam ET, Gumaa SA, El-Hassan AM. Natural Madurella mycetomatis infection in a donkey. Sudan J. Vet. Res. 1990;2:45-47.
33. Brodery RS, Schryver HE, Deubler MJ, Kaplan W, Ajello L. Mycetoma in a dog. J Vet Med Assoc. 1967;151:442-51.
34. Yager JA, Wilcock BP, Lynch JA, Thompson AR. Mycetoma-like granuloma in a cat by Microsporum canis. J Comp Pathol. 1986;96(2):171-6.
35. Ahmed AO, van Vianen W, ten Kate M, van de Sande WW, Van Belkum A, Fahal AH, et al. A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol. 2003;37:29-36.
36. • Fahal AH, Abu Sabaa AH. Mycetoma in children. Trans R Soc Trop Med Hyg. 2010;104:117-2. This recent article is a comprehensive updated review of mycetoma in children.
37. • van de Sande WW, Fahal A, Tavakol M, van Belkum A. Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. Med Mycol. 2010;48:959-68. This article addresses the susceptibility and genetics of mycetoma.
38. Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10:594-604.
39. Oblong JE. Comparison of the impact of environmental stress on male and female skin. Br J Dermatol. 2012;166 Suppl 2:41-4.
40. van de Sande WW, Janse DJ, Hira V, Goedhart H, van der Zee R, Ahmed AO, et al. Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J Immunol. 2006;177:1997-2005.
41. • de Klerk N, de Vogel C, Fahal AH, van Belkum A, van de Sande WW. Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis. Med Mycol. 2012;50:143-51. This recent article is a comprehensive updated review of the genetics of mycetoma.
42. Mahgoub ES, Gumaa SA. El Hassan AM. Immunological status of mycetoma patients. Bull Soc Pathol Exot Filiales. 1977;70:48-54.
43. Mahgoub ES. Experimental infection of athymic nude New Zealand mice, nu nu strain with mycetoma agents. Sabouraudia. 1978;16(3):211-6.
44. Bendl BJ, Mackey D, Al-Saati F, Sheth KV, Ofole SN, Bailey TM. Mycetoma in Saudi Arabia. J Trop Med Hyg. 1987;90:51-9.
45. van de Sande WW, Fahal AH, Verbrugh H, van Belkum A. Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol. 2007;179:3065-74.
46. Chensue SW, Warmington KS, Allenspach EJ, Lu B, Gerard C, Kunkel SL, et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol. 1999;163:165-73.
47. Worda C, Sator MO, Schneeberger C, Jantschev T, Ferlitsch K, Huber JC. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod. 2003;18:262-6.